Overview

  • Product nameAnti-RGS17 / RGSZ2 antibody
    See all RGS17 / RGSZ2 primary antibodies
  • Description
    Rabbit polyclonal to RGS17 / RGSZ2
  • Tested applicationsSuitable for: WBmore details
  • Species reactivity
    Reacts with: Human
  • Immunogen

    Synthetic peptide: EVSLDSRVRE VINRNLLDPN PHMYEDAQLQ IYTLMHRDSF PRFLNSQIYK SFVESTAGSS SES, corresponding to amino acids 148-210 of Human RGS17/ RGSZ2 (NP_036551).

  • Positive control
    • 293T, A431, H1299, HeLa, HepG2, MOLT4 and Raji cell lysates

Properties

  • FormLiquid
  • Storage instructionsShipped at 4°C. Upon delivery aliquot and store at -20°C or -80°C. Avoid repeated freeze / thaw cycles.
  • Storage bufferPreservative: 0.01% Thimerosal (merthiolate)
    Constituents: 20% Glycerol, 1% BSA, PBS, pH 7.0
  • Concentration information loading...
  • PurityImmunogen affinity purified
  • ClonalityPolyclonal
  • IsotypeIgG
  • Research areas

Applications

Our Abpromise guarantee covers the use of ab96675 in the following tested applications.

The application notes include recommended starting dilutions; optimal dilutions/concentrations should be determined by the end user.

Application Abreviews Notes
WB 1/1000. Predicted molecular weight: 24 kDa.

Target

  • FunctionInhibits signal transduction by increasing the GTPase activity of G protein alpha subunits thereby driving them into their inactive GDP-bound form. Binds selectively to G(z)-alpha and G(alpha)-i2 subunits, accelerates their GTPase activity and regulates their signaling activities. The G(z)-alpha activity is inhibited by the phosphorylation and palmitoylation of the G-protein. Negatively regulates mu-opioid receptor-mediated activation of the G-proteins.
  • Tissue specificityPredominantly expressed in the cerebellum. Also expressed in the cortex and medulla. Weakly expressed in a number of peripheral tissues notably spleen, lung and leukocytes.
  • Sequence similaritiesContains 1 RGS domain.
  • Post-translational
    modifications
    Fatty acylated. Heavily palmitoylated in the cysteine string motif.
    N- and O-glycosylated in synapsomal membranes.
    Serine phosphorylated in synapsomal membranes.
    Sumoylated by SUMO1 and SUM02 in synaptosomes. The sumoylated forms act as a scaffold for sequestering mu-opioid receptor-activated G(alpha) subunits.
  • Cellular localizationMembrane. Nucleus. Cytoplasm. Shuttles between the cytoplasm/cell membrane and the nucleus. Anchored to the membrane through palmitoylation.
  • Information by UniProt
  • Database links
  • Alternative names
    • hRGS17 antibody
    • Regulator of G protein signalling 17 antibody
    • Regulator of G protein signalling Z2 antibody
    • Regulator of G-protein signaling 17 antibody
    • RGS-17 antibody
    • RGS17 antibody
    • RGS17_HUMAN antibody
    • RGSZ2 antibody
    see all

Anti-RGS17 / RGSZ2 antibody images

  • Anti-RGS17 / RGSZ2 antibody (ab96675) at 1/1000 dilution + HepG2 whole cell lysate at 30 µg

    Predicted band size : 24 kDa

References for Anti-RGS17 / RGSZ2 antibody (ab96675)

ab96675 has not yet been referenced specifically in any publications.

Product Wall

There are currently no Abreviews or Questions for ab96675.
Please use the links above to contact us or submit feedback about this product.

Please note: All products are "FOR RESEARCH USE ONLY AND ARE NOT INTENDED FOR DIAGNOSTIC OR THERAPEUTIC USE"